Response rates to standard interferon treatment in HCV genotype 3a.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Response rates to standard interferon treatment in HCV genotype 3a.

Journal of Ayub Medical College, Abbottabad : JAMC - 1 Jan 2000

Qureshi Saleem, Batool Uzma, Iqbal Musarrat, Qureshi Omarah, Kaleem Rao, Aziz Hina, Azhar Muhammad

Abstract excerpt

BACKGROUND: Chronic Hepatitis C infection infects almost 130 to 170 million or approximately 2.2-3% of world's population. HCV is one of the main causes of chronic liver disease leading to progressive liver injury, fibrosis, cirrhosis and liver cancer. It is also one of the leading indications for liver transplantation worldwide. The objective of the study was to determine the response of treatment with standard...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic
Share to Interferon-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon alpha-2

Share to Recombinant Proteins

Share to Ribavirin

Share to Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 21067014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.